Pediatrics

Childhood Vaccinations–Frequently Asked Questions by Canadian Parents and Caregivers aims to help pharmacists better support young patients and their caregivers while carrying out vaccinations.

Pediatric asthma is a prevalent chronic respiratory condition, affecting more than 850,000 children in Canada under the age of 14.

A new study from Korea may pose more questions than it answers.

The company says it expects the RSV vaccine—called mRESVIA—to be available in early 2025.

The injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season.

The Executive Program in Child Sex Trafficking & Online Child Sexual Exploitation aims to equip leaders with the knowledge they need to develop policy and practice standards against child sex trafficking.

Tablets and mobile devices can be highly engaging for young children, but they offer few opportunities for them to develop the ability to regulate emotions.

The new shot called Nirsevimab—also known by the brand name Beyfortus—gives babies antibodies that provide passive immunity to RSV.